| Literature DB >> 29131823 |
V E C Pourier1, C J H C M van Laarhoven1, M D I Vergouwen2, G J E Rinkel2, Gert J de Borst1.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2017 PMID: 29131823 PMCID: PMC5683613 DOI: 10.1371/journal.pone.0187479
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of 27 index patients with an IA and ECAA, CA and/or VA.
N = number of patients, UIA = non-ruptured intracranial aneurysm, SAH = subarachnoid hemorrhage, AVM = arteriovenous malformation, IA = intracranial aneurysm, ECAA = extracranial carotid aneurysm, CA = extradural cavernous carotid aneurysm, VA = extracranial vertebral aneurysm.
Available radiologic imaging modality of 3118 patients.
| N | PERCENTAGE (%) | |||
|---|---|---|---|---|
| No angiography | 187 | 6 | ||
| Partially imaged carotid artery | 2293 | 74 | ||
| CTA brain | 1134 | 36) | ||
| MRA brain | 214 | (7) | ||
| DSA brain | 941 | (30) | ||
| DUS carotids | 4 | (<1) | ||
| Completely imaged carotid artery | 638 | (20) | ||
| CTA carotids | 310 | (10) | ||
| MRA carotids | 118 | (4) | ||
| DSA carotids | 18 | (<1) | ||
| DUS carotids | 190 | (6) | ||
| Intra- and extradural simultaneously | 17 | 63 | ||
| ECAA prior to IA | 1 | (4) | ||
| IA prior to ECAA | 9 | (33) | ||
| Time, median (y) | 8.9 | (3.4–23) | ||
Data in n = number of patients (%). Median, range (y) in years. CTA = computed tomography angiography, MRA = magnetic resonance angiography, DSA = digital subtraction angiography, DSA = digital subtraction angiography, ECAA = extracranial carotid artery aneurysm, IA = intracranial aneurysm
Characteristics of 27 patients with an ECAA.
| N | PERCENTAGE (%) | |||
|---|---|---|---|---|
| 15 | 56 | |||
| Diabetes | 1 | 4 | ||
| Vascular | 12 | 44 | ||
| TIA/Ischemic stroke | 5 | 19 | ||
| Connective tissue disorder | 2 | 7 | ||
| Trauma in cervical region | 0 | 0 | ||
| Polycystic kidney disease | 1 | 4 | ||
| Never | 7 | 26 | ||
| Quit smoking | 7 | 26 | ||
| Current smoker | 9 | 33 | ||
| Unknown | 4 | 15 | ||
| None | 12 | 4 | ||
| Anti-hypertensive drugs | 9 | 33 | ||
| Anti-thrombotic drugs | 5 | 19 | ||
| Mono-therapy | 4 | 15 | ||
| Multiple-therapy | 1 | 4 | ||
| Lipid-lowering drugs | 3 | 11 | ||
| Unknown | 3 | 11 | ||
| Aneurysm | 2 | 7 | ||
| Cardiovascular | 8 | 30 | ||
| CTD | 0 | 0 | ||
| PCKD | 1 | 4 | ||
| Unknown | 8 | 27 | ||
| Asymptomatic | 24 | 89 | ||
| Ipsilateral ischemic stroke | 1 | 4 | ||
| Horner’s syndrome | 1 | 4 | ||
| Local pain | 1 | 4 | ||
N = Number. of patients. ECAA = extracranial carotid aneurysm. CTD = connective tissue disease, PCKD = Polycystic kidney disease
Aneurysm characteristics.
| IA, N | PERCENTAGE (%) | ECAA, N | PERCENTAGE (%) | ||
|---|---|---|---|---|---|
| 17 | 63 | 0 | |||
| Left | 6 | 16 | 8 | 30 | |
| Right | 10 | 26 | 12 | 44 | |
| Bilateral | 11 | 58 | 7 | 26 | |
| CCA | 0 | ||||
| ECA | 0 | ||||
| ICA | 34 | 100 | |||
| Extradural cavernous carotid artery | 6 | ||||
| Extracranial vertebral artery | 2 | ||||
| Saccular | 17 | 50 | |||
| Fusiform | 17 | 50 | |||
| Saccular | 8.4 (4–13) | ||||
| Fusiform | 9.2 (6–12.5) | ||||
| Dissection | 5 | 15 | |||
| CTD | 2 | 6 | |||
| Not reported | 28 | 79 | |||
b Patients with additional extradural cavernous carotid and vertebral artery aneurysm, not included in analysis.
Data in: n = number of aneurysms. IA = intracranial aneurysm, ECAA = extracranial carotid aneurysm, CCA = common carotid artery, ECA = external carotid artery, ICA = internal carotid artery, CTD = connective tissue disorder.